With the green light given for a cannabis testing laboratory to begin operations, Missouri’s medical marijuana program supply chain is now complete and will soon be serving patients.
Oregon’s first-of-its-kind ballot measure to legalize psilocybin therapy has the potential to help ease mental suffering for terminally ill people, a medical doctor says in a new TV ad for the initiative.
Nevada’s recreational marijuana sales have largely recovered, having slumped in the spring from some of the strictest coronavirus shutdown measures in the nation and dwindling numbers of tourists visiting Las Vegas.
Workers in Canada who have toked up recently don’t appear to have faced any greater risk of a workplace injury than those who abstained, according to a new study out this week, suggesting that cannabis use isn’t necessarily linked to sloppiness on the job.
If New Jersey voters approve a marijuana legalization referendum on their ballots next week, sales in the Garden State could get rolling at record speed.
A strong majority of Kansas residents support legalizing marijuana for adult use by a three-to-one margin, according to a new poll.
Support for legalizing marijuana in New York outpaces opposition by a margin of two to one, according to a new poll.
The European Parliament voted last week to raise industrial hemp THC limits from 0.2 percent to 0.3 percent, aligning them with most other programs including the U.S., Hemp Industry Daily reports.
Voters in South Dakota are poised to approve two separate ballot measures next month that would legalize marijuana and allow patients to access medical cannabis.
The Marijuana Policy Project has long been a leader in funding cannabis reform at the state and federal levels, but the current election season demonstrates that MPP’s role is shifting in a significant way – toward a more collaborative position with industry trade associations and large MJ companies.